Shyamala Navada, MD, is an Associate Professor of Medicine Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai in New York City. She specializes in clinical and translational research in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), focusing on designing early phase clinical trials to improve patient outcomes. Dr. Navada has presented her research at national and international conferences and is involved in educating community physicians and patients on the treatment of MDS.
As an adjunct associate professor, Dr. Navada is a faculty member of The Tisch Cancer Institute and has a Master of Science degree in Clinical Research from Icahn. She has served as a principal investigator on multiple investigator-initiated and industry-sponsored trials, with a particular interest in novel candidate drugs for MDS and AML. Dr. Navada's expertise and dedication to advancing the field of hematology and oncology make her a valuable asset to the medical community.
Generated from the website